• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4-disubstituted thiazoles

Recent Advances in the Study of 2-(2-Bromophenyl)thiazole-4-carbaldehyde (CAS: 885279-14-1) in Chemical Biology and Pharmaceutical Research

2-(2-Bromophenyl)thiazole-4-carbaldehyde (CAS: 885279-14-1) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of novel therapeutics targeting infectious diseases and cancer. Recent studies have highlighted its potential as a versatile scaffold for drug discovery, owing to its unique chemical properties and ability to interact with multiple biological targets. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and applications in pharmaceutical research.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 2-(2-Bromophenyl)thiazole-4-carbaldehyde as a precursor for the synthesis of thiazole-based inhibitors targeting bacterial efflux pumps. The study demonstrated that derivatives of this compound exhibited significant activity against multidrug-resistant strains of Staphylococcus aureus, with minimal cytotoxicity to human cells. The researchers employed a combination of computational modeling and in vitro assays to optimize the compound's structure, leading to improved potency and selectivity.

Another notable advancement was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where 2-(2-Bromophenyl)thiazole-4-carbaldehyde was utilized to develop a new class of kinase inhibitors. The study focused on its role in modulating the activity of protein kinases involved in cancer cell proliferation. The results indicated that certain derivatives of this compound could effectively inhibit key oncogenic kinases, such as EGFR and BRAF, suggesting its potential as a lead compound for anticancer drug development.

Recent synthetic methodologies have also improved the accessibility of 2-(2-Bromophenyl)thiazole-4-carbaldehyde. A 2023 publication in Organic Process Research & Development detailed a scalable and cost-effective synthesis route, which reduced the number of steps and improved overall yield. This advancement is particularly significant for large-scale pharmaceutical production, as it addresses previous challenges related to the compound's availability and purity.

In addition to its applications in drug discovery, 2-(2-Bromophenyl)thiazole-4-carbaldehyde has been investigated for its role in chemical biology. A 2024 study in ACS Chemical Biology explored its use as a fluorescent probe for detecting reactive oxygen species (ROS) in live cells. The compound's thiazole moiety was found to exhibit strong fluorescence upon interaction with ROS, making it a valuable tool for studying oxidative stress in disease models.

In conclusion, 2-(2-Bromophenyl)thiazole-4-carbaldehyde (CAS: 885279-14-1) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its promising biological activities, positions it as a valuable asset in the development of new therapeutics. Future research is expected to further explore its potential in targeting emerging diseases and optimizing its pharmacological properties.

• 20949-81-9(2-Phenyl-1,3-thiazole-4-carbaldehyde)
• 885280-21-7(4-Thiazolemethanamine,2-(2-bromophenyl)-)
• 885278-96-6(2-(3,5-dimethylphenyl)-1,3-thiazole-4-carbaldehyde)
• 885279-08-3(2-(3-ethylphenyl)-1,3-thiazole-4-carbaldehyde)
• 21160-50-9(2-(4-Bromophenyl)thiazole-4-carboxylic acid)
• 21166-30-3(2-(4-Bromo-phenyl)-thiazole-4-carbaldehyde)
• 885278-99-9(2-(3-Aminophenyl)thiazole-4-carbaldehyde)
• 885279-05-0(2-(3,4-dimethylphenyl)-1,3-thiazole-4-carbaldehyde)
• 885279-27-6(2-(4-ethylphenyl)-1,3-thiazole-4-carbaldehyde)
• 750624-69-2(2-(3-Bromo-phenyl)-thiazole-4-carbaldehyde)